QUANTUM-SI INC (QSI) Fundamental Analysis & Valuation

NASDAQ:QSI • US74765K1051

Current stock price

0.9058 USD
-0.03 (-3.7%)
At close:
0.92 USD
+0.01 (+1.57%)
Pre-Market:

This QSI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. QSI Profitability Analysis

1.1 Basic Checks

  • In the past year QSI has reported negative net income.
  • QSI had a negative operating cash flow in the past year.
  • In the past 5 years QSI always reported negative net income.
  • QSI had a negative operating cash flow in each of the past 5 years.
QSI Yearly Net Income VS EBIT VS OCF VS FCFQSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • QSI has a worse Return On Assets (-41.26%) than 84.21% of its industry peers.
  • QSI's Return On Equity of -46.02% is on the low side compared to the rest of the industry. QSI is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
ROA -41.26%
ROE -46.02%
ROIC N/A
ROA(3y)-38.06%
ROA(5y)-33.38%
ROE(3y)-42.74%
ROE(5y)-37.01%
ROIC(3y)N/A
ROIC(5y)N/A
QSI Yearly ROA, ROE, ROICQSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • QSI's Gross Margin of 47.33% is in line compared to the rest of the industry. QSI outperforms 54.39% of its industry peers.
  • The Profit Margin and Operating Margin are not available for QSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QSI Yearly Profit, Operating, Gross MarginsQSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

7

2. QSI Health Analysis

2.1 Basic Checks

  • QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, QSI has more shares outstanding
  • The number of shares outstanding for QSI has been increased compared to 5 years ago.
  • QSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
QSI Yearly Shares OutstandingQSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
QSI Yearly Total Debt VS Total AssetsQSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 0.11, we must say that QSI is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of QSI (0.11) is worse than 68.42% of its industry peers.
  • There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.11
ROIC/WACCN/A
WACC10.91%
QSI Yearly LT Debt VS Equity VS FCFQSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 7.64 indicates that QSI has no problem at all paying its short term obligations.
  • The Current ratio of QSI (7.64) is better than 91.23% of its industry peers.
  • A Quick Ratio of 7.50 indicates that QSI has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 7.50, QSI belongs to the top of the industry, outperforming 92.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.64
Quick Ratio 7.5
QSI Yearly Current Assets VS Current LiabilitesQSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

3

3. QSI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.76% over the past year.
  • The Revenue for QSI has decreased by -20.34% in the past year. This is quite bad
EPS 1Y (TTM)26.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.22%
Revenue 1Y (TTM)-20.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-62.16%

3.2 Future

  • QSI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.31% yearly.
  • QSI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 113.09% yearly.
EPS Next Y12.6%
EPS Next 2Y10.88%
EPS Next 3Y11.81%
EPS Next 5Y11.31%
Revenue Next Year-61.98%
Revenue Next 2Y65.23%
Revenue Next 3Y110.04%
Revenue Next 5Y113.09%

3.3 Evolution

QSI Yearly Revenue VS EstimatesQSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
QSI Yearly EPS VS EstimatesQSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -0.2 -0.4 -0.6 -0.8

0

4. QSI Valuation Analysis

4.1 Price/Earnings Ratio

  • QSI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year QSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QSI Price Earnings VS Forward Price EarningsQSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QSI Per share dataQSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.88%
EPS Next 3Y11.81%

0

5. QSI Dividend Analysis

5.1 Amount

  • No dividends for QSI!.
Industry RankSector Rank
Dividend Yield 0%

QSI Fundamentals: All Metrics, Ratios and Statistics

QUANTUM-SI INC

NASDAQ:QSI (4/24/2026, 8:03:56 PM)

Premarket: 0.92 +0.01 (+1.57%)

0.9058

-0.03 (-3.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-03
Earnings (Next)05-07
Inst Owners32.58%
Inst Owner Change0.31%
Ins Owners3.9%
Ins Owner Change6.05%
Market Cap195.99M
Revenue(TTM)2.44M
Net Income(TTM)-101.34M
Analysts77.14
Price Target2.55 (181.52%)
Short Float %12.7%
Short Ratio6.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.31%
Min EPS beat(2)-23.16%
Max EPS beat(2)35.78%
EPS beat(4)2
Avg EPS beat(4)7.11%
Min EPS beat(4)-23.16%
Max EPS beat(4)35.78%
EPS beat(8)5
Avg EPS beat(8)7.8%
EPS beat(12)9
Avg EPS beat(12)9.01%
EPS beat(16)11
Avg EPS beat(16)3.61%
Revenue beat(2)0
Avg Revenue beat(2)-24.38%
Min Revenue beat(2)-41.4%
Max Revenue beat(2)-7.37%
Revenue beat(4)0
Avg Revenue beat(4)-28.15%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)-7.37%
Revenue beat(8)1
Avg Revenue beat(8)-18.43%
Revenue beat(12)2
Avg Revenue beat(12)-23.87%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.25%
PT rev (3m)-6.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.81%
EPS NY rev (1m)4.93%
EPS NY rev (3m)4.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-69.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-85.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 80.45
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS0.01
BVpS1.02
TBVpS1.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -41.26%
ROE -46.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.33%
FCFM N/A
ROA(3y)-38.06%
ROA(5y)-33.38%
ROE(3y)-42.74%
ROE(5y)-37.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.51%
Cap/Sales 103.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.64
Quick Ratio 7.5
Altman-Z 0.11
F-Score2
WACC10.91%
ROIC/WACCN/A
Cap/Depr(3y)94.77%
Cap/Depr(5y)250.89%
Cap/Sales(3y)247.49%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.22%
EPS Next Y12.6%
EPS Next 2Y10.88%
EPS Next 3Y11.81%
EPS Next 5Y11.31%
Revenue 1Y (TTM)-20.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-62.16%
Revenue Next Year-61.98%
Revenue Next 2Y65.23%
Revenue Next 3Y110.04%
Revenue Next 5Y113.09%
EBIT growth 1Y8.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.56%
EBIT Next 3Y8.37%
EBIT Next 5Y10.06%
FCF growth 1Y-5.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.88%
OCF growth 3YN/A
OCF growth 5YN/A

QUANTUM-SI INC / QSI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of QUANTUM-SI INC (QSI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to QSI.


What is the valuation status of QUANTUM-SI INC (QSI) stock?

ChartMill assigns a valuation rating of 0 / 10 to QUANTUM-SI INC (QSI). This can be considered as Overvalued.


Can you provide the profitability details for QUANTUM-SI INC?

QUANTUM-SI INC (QSI) has a profitability rating of 0 / 10.


How financially healthy is QUANTUM-SI INC?

The financial health rating of QUANTUM-SI INC (QSI) is 7 / 10.